Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis

Recruiting N/A Interventional Study
Neonatal Epilepsy Infantile Epilepsy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
600 (estimated)
Sponsor
Boston Children's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this study is to discover new genetic causes of infantile epilepsies and evaluate the impact of these discoveries on infants with epilepsy and their families.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Infant Criteria Inclusion Criteria: * Seizure onset at less than 12 months of age * Enrollment within 6 weeks of seizure-related presentation * Patient at Boston Children's Hospital Exclusion Criteria: * Simple febrile seizures * Acute provoked seizures (e.g., due to sepsis, hemorrhage, electrol…
Contacts

Beth R Sheidley, MS

8572185533

beth.sheidley@childrens.harvard.edu

CONTACT